Aptevo Therapeutics (APVO) Institutional Ownership $0.28 -0.02 (-8.20%) Closing price 04:00 PM EasternExtended Trading$0.27 -0.01 (-3.41%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)CurrentInstitutional OwnershipPercentage8.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$313.86MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$87.67K Get APVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APVO Institutional Buying and Selling by Quarter Aptevo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025 Virtu Financial LLC21,627$93K0.0%-48.5%4.241% 8/15/2024 Armistice Capital LLC749,234$229K0.0%N/A18.359% 11/15/2023 Sabby Management LLC1,334,169$440K0.3%N/A11.581% 11/15/2023 Armistice Capital LLC1,235,000$408K0.0%N/A10.717% 2/1/2023 Bank of Montreal Can10,000$61K0.0%N/A0.196% 11/15/2022 Cantor Fitzgerald L. P.133,700$406K0.0%N/A2.627% 11/7/2022 Virtu Financial LLC28,421$86K0.0%+122.6%0.558% 12/10/2021 Towercrest Capital Management211,227$3.26M0.6%N/A4.313% 12/8/2021 Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948% 11/15/2021 Franklin Resources Inc.15,650$242K0.0%N/A0.320% Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2021 GSA Capital Partners LLP13,651$211K0.0%N/A0.279% 11/12/2021 Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931% 11/9/2021BlackRock Inc.55,394$856K0.0%+1.9%1.133% 11/5/2021 Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954% 8/17/2021 Balyasny Asset Management LLC18,012$404K0.0%-70.6%0.405% 8/17/2021 Boothbay Fund Management LLC15,350$344K0.0%+4.9%0.345% 8/16/2021 Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127% 8/16/2021 Morgan Stanley8,364$187K0.0%+163.4%0.188% 8/16/2021 Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225% 8/16/2021 State Street Corp10,973$246K0.0%N/A0.247% 8/13/2021 Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594% 8/13/2021 Anson Funds Management LP35,587$798K0.1%-26.6%0.800% 8/13/2021 Northern Trust Corp22,652$508K0.0%+170.7%0.509% 8/13/2021QS Investors LLC15,650$352K0.0%+37.3%0.352% 8/13/2021 Geode Capital Management LLC38,917$872K0.0%+8.8%0.875% 8/13/2021 Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028% 5/17/2021 Schonfeld Strategic Advisors LLC9,700$296K0.0%-12.6%0.218% 5/14/2021 RTW Investments LP281,402$8.59M0.1%-2.4%6.324% 5/14/2021 Dynamic Technology Lab Private Ltd14,022$428K0.0%+6.2%0.315% 5/13/2021QS Investors LLC11,400$348K0.0%N/A0.256% 5/13/2021 JBF Capital Inc.3,907$119K0.0%+49.9%0.088% 5/13/2021 Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702% 5/13/2021 Bank of New York Mellon Corp9,964$305K0.0%N/A0.224% 5/13/2021 Bank of Montreal Can25,280$674K0.0%-20.1%0.568% 5/12/2021 Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804% 5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294% 3/8/2021 Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% (Data available from 1/1/2016 forward) APVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Aptevo Therapeutics shares: Sabby Management LLC ($440K), and Armistice Capital LLC ($229K), Virtu Financial LLC ($93K).Learn more on APVO's institutional investors. What percentage of Aptevo Therapeutics stock is owned by institutional investors? 8.06% of Aptevo Therapeutics stock is owned by institutional investors. Learn more on APVO's institutional investor holdings. Which institutional investors have been buying Aptevo Therapeutics stock? The following institutional investors have purchased Aptevo Therapeutics stock in the last 24 months: Armistice Capital LLC ($1.98M), and Sabby Management LLC ($1.33M). How much institutional buying is happening at Aptevo Therapeutics? Institutional investors have bought a total of 3,318,403 shares in the last 24 months. This purchase volume represents approximately $51.38B in transactions. Which Aptevo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Aptevo Therapeutics stock in the last 24 months: Virtu Financial LLC ($20.34K). How much institutional selling is happening at Aptevo Therapeutics? Institutional investors have sold a total of 20,340 shares in the last 24 months. This volume of shares sold represents approximately $87.67K in transactions. Related Companies PHIO Major Shareholders RNAZ Major Shareholders ADXN Major Shareholders CDIO Major Shareholders BTAI Major Shareholders CARM Major Shareholders PRTG Major Shareholders BCLI Major Shareholders IBIO Major Shareholders TSBX Major Shareholders This page (NASDAQ:APVO) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APVO Stock Free APVO Stock Alerts